Protein-protein interaction-based high throughput screening for adenylyl cyclase 1 inhibitors: Design, implementation, and discovery of a novel chemotype is a research paper published in Frontiers in Pharmacology (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS NIH HHS
Grant: T32 GM144636
NINDS NIH HHS
Grant: R01 NS119917
NINDS NIH HHS
Grant: R33 NS111070
National Institutes of Health
Grant: 1R61NS111070-01
Non-opioids for inflammatory pain: Adenylyl cyclase 1 as a novel target
National Institutes of Health
Grant: 5T32GM008365-20
Predoctoral Training Program in Biotechnology
National Institutes of Health
Grant: 1P30CA086862-01
Core--Clinical trials support group
FWCI
0.37
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals